In the unfolded protein response (UPR), stress in the endoplasmic reticulum (ER)
Introduction
During the unfolded protein response (UPR), protein folding stress in the lumen of the endoplasmic reticulum leads to oligomerization of the transmembrane kinase/endoribonuclease Ire1 and the processing of a cytoplasmic mRNA to yield splicing intermediates with 2 0 ,3 0 -cyclic phosphate (PO 4 ) and 5 0 -hydroxyl (OH) termini (Gonzalez et al., 1999) . In budding yeast, excision of an intron from the HAC1 u mRNA ('u' denoting the unspliced mRNA) by Ire1 is followed by exon ligation by the multifunctional Trl1 RNA ligase (Sidrauski et al., 1996) involving 5 0 -phosphorylation of the 5 0 -OH product, adenylylation of the 5 0 -PO 4 , and resolution of the 2 0 ,3 0 -cyclic PO 4 to a 2 0 -PO 4 /3 0 -OH. The newly produced 3 0 -OH serves as the nucleophile to attack the 5 0 -adenylate intermediate, yielding a ligated mRNA with an internal 2 0 -PO 4 . The 2 0 -PO 4 is assumed to be removed in a separate reaction by the 2 0 -phosphotransferase, Tpt1, in a NAD + -dependent reaction (Culver et al., 1997) . The spliced mRNA, called HAC1 s mRNA ('s' denoting spliced mRNA) (Li et al., 2018) , is translated into a transcription factor that activates the expression of dozens of stress-response genes to mitigate proteinfolding stress (Ron and Walter, 2007) . In addition, Hac1 activates its own promoter in a positive feedback loop that generates more HAC1 u and permits sustained UPR activation (Ogawa and Mori, 2004 ) ( Figure 1A ). Control of this positive feedback loop ensures UPR suppression during normal growth and rapid activation upon stress exposure. To facilitate the control of UPR activation, HAC1 u contains cis-regulatory elements that suppress unintended translation and promote rapid processing. A long-range base-pairing interaction between the 5 0 -UTR and intron prevents ribosome initiation to suppress translation of HAC1 u mRNA (Chapman and Walter, 1997; Di Santo et al., 2016) . If a ribosome initiates on HAC1 u , translation through the 5 0 -exon/intron junction yields a truncated protein with an intron-encoded C-terminal peptide 'degron' that targets it for ubiquitylation and degradation (Di Santo et al., 2016) . A stem-loop (the '3 0 -BE') in the 3 0 -untranslated region of HAC1 tethers the mRNA to the ER membrane, ensuring rapid Ire1-mediated cleavage following ER stress (Aragó n et al., 2009) .
Previous work found unexpected roles for RNA decay and repair enzymes acting on HAC1 mRNA in the budding yeast unfolded protein response. Ire1 is a metal-ion-independent endonuclease that produces RNA cleavage products with 5 0 -OH termini (Gonzalez et al., 1999) . In cells lacking the cytoplasmic 5 0 fi3 0 exonuclease Xrn1, HAC1 splicing intermediates accumulate with 5 0 -PO 4 termini, indicating that a RNA 5 0 -kinase phosphorylates HAC1 processing intermediates and that not all HAC1 splicing intermediates are productively ligated (Harigaya and Parker, 2012; Peach et al., 2015) . In addition to its role in HAC1 exon ligation, Trl1 is required to relieve translational attenuation of HAC1 s by an unknown mechanism (Mori et al., 2010) . In cells expressing the T4 bacteriophage RNA repair enzymes PNK and RNL1 in lieu of TRL1, ligated HAC1 molecules contained single nucleotide deletions from the 3 0 -terminus of the 5 0 -exon, indicating that a 3 0 fi5 0 exonucleolytic activity acts on the cleaved 5 0 -exon (Schwer et al., 2004) and nuclear 3 0 fi5 0 decay of HAC1 u liberates the 3 0 -BE, tuning the activation potential of the UPR (Sarkar et al., 2018) . Recent studies showed that RNA decay also plays a role in the UPR in other organisms. During UPR activation in the fission yeast, Ire1 incises specific mRNAs to promote their stabilization or degradation (Guydosh et al., 2017; Kimmig et al., 2012) . This mode of Ire1 cleavage is similar to the metazoan Regulated Ire1-Dependent Decay (RIDD) pathway wherein Ire1 incises some ER-localized mRNAs and the cleavage products are degraded by Xrn1 and the cytoplasmic exosome (Hollien and Weissman, 2006) . eLife digest Like any economical factory, cells tune the size of their protein assembly line to suit demand. Proteins consist of strings of amino acids, built from template molecules called mRNAs, that must be folded into specific 3D structures for them to work correctly. If these protein strings are produced faster than they can be folded, the cell triggers the unfolded protein response. This response slows protein production, gets rid of any misshapen proteins, and increases the size of the protein assembly line.
It is not clear exactly how the unfolded protein response is tuned, though an mRNA molecule called HAC1 is known to signal the response. First, enzymes remove a short section of HAC1 and join the remaining parts back together in a process called splicing. Spliced HAC1 is then used as a template to make a protein that activates the unfolded protein response.
To understand more about this processing of HAC1, Cherry et al. studied yeast cells that had mutated, non-working versions of some of the enzymes that repair and degrade RNA. This revealed that the splicing of HAC1 competes with another process that breaks down mRNA. Under normal conditions, this means that HAC1 is degraded before it can trigger the unfolded protein response. In addition, for the cell to trigger the unfolded protein response, it needs to break down the part of HAC1 that is removed during splicing. Otherwise, the removed section interferes with the spliced HAC1 mRNA, preventing it from being a signal to activate the unfolded protein response.
Cherry et al. also found that a unique, chemically modified fragment of HAC1 mRNA was protected from degradation. They do not know how the unique chemical modification regulates the unfolded protein response, but stabilizing modifications are generally useful in RNA biology.
Understanding how the unfolded protein response is tuned could help researchers to find new ways to treat conditions where it does not work correctly, such as neurodegeneration, diabetes and cancer. Additionally, researchers are already trying to develop treatments for a number of diseases that work by inserting new RNA molecules into cells. Understanding how the chemical modification discovered by Cherry et al. protects RNAs from degradation could therefore improve the effectiveness of such treatments. translated into a transcription factor (Hac1, purple) that upregulates the HAC1 gene itself (a positive feedback loop), as well as several chaperones and heat shock proteins that resolve the stress. (B) Yeast cells with mutations in RNA repair and decay factors were serially diluted (5-fold) and spotted onto agar media (YPD and YPD containing tunicamycin (Tm; 0.16 mg/mL)), grown at 30˚C for 2 days, and photographed. The '10x tRNA' plasmid encodes 10 intronless tRNAs that bypass the lethality of trl1D and tpt1D (Cherry et al., 2018) . The top panels depict cells with deletions of the RNA ligase TRL1 and the bottom panels depict growth of cells deletions of the 2 0 -phosphotransferase TPT1. (C) HAC1 processing in RNA repair and decay mutants (3 0 -exon probe). HAC1 u cleavage and ligation were analyzed in mutants of TRL1 RNA ligase and TPT1 2 0 -phosphotransferase by denaturing acrylamide gel northern blotting using a probe to the HAC1 3 0 -exon. Diagrams of HAC1 u , HAC1 s , and HAC1 splicing intermediates are drawn next to predominant bands (see Table 1 Here, we used budding yeast with mutations in RNA repair and decay enzymes to show that HAC1 splicing intermediates are processed at multiple steps prior to ligation, limiting the impact of spurious Ire1 activation and unintentional HAC1 cleavage. Our studies also show that incompletely spliced HAC1 s mRNA is targeted for degradation, which may be used to attenuate the UPR.
*

Results
RNA repair mutants have unique HAC1 mRNA processing defects
We recently showed that the functions of the essential RNA repair enzymes Trl1 and Tpt1 in budding yeast can be genetically bypassed by the expression of intronless tRNAs, which are able to support translation in trl1D and tpt1D cells (Cherry et al., 2018) . Because Trl1 is required for HAC1 s ligation and subsequent UPR activation (Sidrauski et al., 1996) , trl1D cells are unable to grow on media containing tunicamycin ( Figure 1B ). In contrast, the general growth defect of tpt1D cells is unaffected by tunicamycin (Cherry et al., 2018 ) ( Figure 1B ), indicating that these cells can activate the UPR. Combination of trl1D and tpt1D with mutations in 5 0 fi3 0 and 3 0 fi5 0 decay factors xrn1D or ski2D led to more pronounced growth defects than the single deletions, but removal of these decay factors did not affect the growth deficit of trl1D or tpt1D cells on tunicamycin ( Figure 1B) .
Given the multiple enzymatic roles of Trl1 and Tpt1 during RNA repair, we sought to understand how the loss of these enzymes affected HAC1 mRNA splicing. We visualized HAC1 splicing intermediates by northern blotting with probes for the HAC1 3 0 -exon and intron ( Figure 1C ,D) and found cleavage and ligation of HAC1 u in wild-type cells in the presence of tunicamycin, leading to high levels of HAC1 s . As expected, trl1D cells lacking RNA ligase activity did not produce HAC1 s upon tunicamycin treatment. However, cleaved 3 0 -exon and intron accumulated upon tunicamycin treatment in trl1D cells ( Figure 1C,D) , indicating a defect in 3 0 -exon decay. Cleaved HAC1 3 0 -exon often appears as a smear of products between~450 nt and~575 nt ( Figure 1C) ; we attribute this size heterogeneity to differences in poly(A) tail presence or length, as the 5 0 -ends of these products occur uniformly at one site ( Figure 5A ).
The 2 0 -phosphotransferase Tpt1 is essential in budding yeast to remove 2 0 -phosphate groups from ligated tRNAs (Culver et al., 1997) , but its role in HAC1 mRNA processing during the UPR has not been defined. Although the growth of tpt1D cells is unaffected by tunicamycin ( Figure 1B) , specific perturbations of HAC1 processing in tpt1D cells indicate that residual 2 0 -phosphate groups on HAC1 mRNA cause defects in cleavage and ligation. Whereas tunicamycin treatment led to cleavage of HAC1 u and production of HAC1 s in tpt1D cells, the levels of HAC1 s ( Figure 1C ) and excised intron ( Figure 1D ) are lower than in wild-type cells. In addition, despite the fact that tpt1D cells have functional RNA ligase, cleaved 3 0 -exon accumulated to high levels upon tunicamycin treatment ( Figure 1C, lane 6) .
Kinase-mediated decay of cleaved HAC1 3 0 -exon competes with its ligation
To further investigate the 3 0 -exon decay defect, we examined splicing of HAC1 in xrn1D cells. We found that HAC1 s accumulated in the absence of tunicamycin ( Figures 1C, 2A , D, E and F). This promiscuous processing was surprising given that HAC1 s is undetectable in wild-type cells under normal growth conditions, and it suggested that Xrn1 somehow limits production of HAC1 s . In xrn1D cells, 3 0 -exon accumulated to modest levels in both the absence and presence of tunicamycin ( Figure 2A ), whereas in trl1D cells, HAC1 3 0 -exon accumulated to higher levels ( Figure 2A and B) . Moreover, the abundance of 3 0 -exon was similar in trl1D and trl1D xrn1D cells (Figure 2A ), indicating that Xrn1 requires Trl1 for 3 0 -exon degradation. Previous work showed that Trl1 5 0 -kinase activity is required for the Xrn1-mediated degradation of excised tRNA introns in budding yeast (Wu and Hopper, 2014) , and we considered whether this pathway also degraded HAC1 3 0 -exon. Indeed, expression of a kinase-inactive version of Trl1 (Trl1-D425N) (Wang et al., 2006) did not restore Xrn1-mediated decay of the 3 0 -exon ( Figure 2B ), affirming that the 5 0 -kinase activity of Trl1 ligase is required for Xrn1-mediated suppression of HAC1 splicing. We also tested whether the ligase activity of Trl1 affected HAC1 3 0 -exon abundance using an adenylyl-transferase/ligase defective allele (Trl1-K114A) (Sawaya et al., 2003) and found that additional 3 0 -exon accumulates compared to wild-type ( Figure 2C ), indicating that ligation also contributes to processing of free 3 0 -exon. Furthermore, we examined the accumulation of 3 0 -exon in cells lacking Dxo1, a distributive, 5 0 -phosphate-dependent 5 0 fi3 0 exonuclease (Chang et al., 2012) , and found that HAC1 3 0 -exon accumulation was unaffected in dxo1D cells. In addition, the levels of 3 0 -exon were similar in xrn1D and dxo1D xrn1D cells ( Figure 2D ), indicating that Xrn1 is the primary factor responsible for 5 0 fi3 0 decay of the 3 0 -exon. Together these data indicate that ligation and Xrn1-mediated 5 0 fi3 0 decay compete for the 5 0 -phosphorylated 3 0 -exon splicing intermediate ( Figure 2G , top). Examination of HAC1 splicing in trl1D cells expressing the E. coli RtcB RNA ligase (Tanaka et al., 2011) provided additional evidence of a competition between ligation and decay. RtcB catalyzes ligation of 2 0 ,3 0 -cyclic PO 4 and 5 0 -OH RNA termini via a unique mechanism involving nucleophilic attack of the 5 0 -OH on a 3 0 -guanylate intermediate; accordingly, RtcB does not have 5 0 -kinase activity (Chakravarty et al., 2012) . We found that upon tunicamycin treatment, HAC1 s was produced in trl1D (RtcB) cells ( Figure 2E ), as shown previously (Tanaka et al., 2011) . However, under normal growth conditions, trl1D (RtcB) cells also promiscuously spliced HAC1 s at levels similar to xrn1D cells ( Figure 2E and F). We propose that because HAC1 ligation by RtcB does not involve a 5 0 -phosphate intermediate, Xrn1 is unable to degrade the 5 0 -hydroxyl exon product of Ire1 cleavage, tipping the balance toward ligation and producing HAC1 s under normal growth conditions ( Figure 2G , bottom). Thus Xrn1-mediated decay of HAC1 3 0 -exon appears to counteract a low rate of background Ire1 cleavage to ensure the UPR is only activated when legitimately stressed.
Kinase-mediated decay of excised intron is required for HAC1 s translation
In several instances, cells with mutations in repair and decay factors can splice HAC1 but fail to grow on media containing tunicamycin ( Figure 3A ), indicating that HAC1 s production is not sufficient to activate the UPR. We assayed expression of KAR2, an ER chaperone and direct target of the Hac1 transcription factor (Kohno et al., 1993) , and found that all repair and decay mutants express 0 -exon reveals that xrn1D (lanes 3 and 4) and trl1D (lanes 5 and 6) are mutations sufficient to cause 3 0 -exon to accumulate compared to wild-type. In xrn1D cells, the accumulation appears tunicamycin-treatment independent, whereas in trl1D cells the accumulation increases upon treatment. The accumulation is also present in xrn1D trl1D cells (lanes 7 and 8). (B) Decay of cleaved HAC1 3 0 -exon requires the catalytic activity of Trl1 5 0 -kinase. We expressed a kinase-inactive missense mutant of Trl1 (Wang et al., 2006) , trl1-D425N, to assess the contribution of RNA 5 0 -kinase activity to decay of HAC1 intermediates. Expression of trl1-D425N (lanes 5 and 6) caused similar accumulation of 3 0 -exon as in the trl1D deletion, and xrn1D trl1-D425N cells have levels of 3 0 -exon similar to trl1-D425N alone (compare lanes 6 and 8), indicating that Trl1 5 0 -kinase activity is required for Xrn1-mediated decay. (C) 5 0 -kinase and ligase domains contribute to the abundance of liberated 3 0 -exon. We expressed a ligase-inactive missense mutant of Trl1 (Sawaya et al., 2003) , trl1-K114A, to assess the contribution of ligation activity to levels of HAC1 intermediates. Expression of trl1-K114A (lanes 5 and 6) lead to a moderate accumulation of 3 Figure 3C ). The intron decay products that accumulate in these cells are indicative of kinase-mediated decay: in xrn1D cells that lack Xrn1 but have 5 0 -kinase activity, intron products appear with a few distinct, smaller products below the fulllength 252 nt excised intron ( Figure 3C, lanes 3 and 4) . In contrast, excised intron accumulated as a uniform,~250 nt product in trl1D cells that lack 5 0 -kinase activity ( Figure 3C , lanes 5-8), independent of XRN1 status. Moreover, production of shorter decay products (like those present in xrn1D cells) was dependent on Trl1 5 0 -kinase catalytic activity ( Figure 3D ). Interestingly, expression of the adenylyl-transferase-dead/ligase-dead allele, trl1-K114A, also led to accumulation of some free HAC1 intron ( Figure 3I ), potentially indicating a role for ligation in the processing of liberated HAC1 intron. Together, these data show that excised HAC1 intron is a substrate for kinase-mediated decay with strict dependence on a 5 0 -phosphorylation step to promote 5 0 fi3 0 decay. A single deletion of Dxo1 had no effect on HAC1 intron degradation ( Figure 3E) ; however, the sizes of smaller decay products in xrn1D dxo1D cells were subtly different than in xrn1D cells ( Figure 3E ), indicating that Dxo1 and other exonucleases partially degrade excised HAC1 intron, but only when it accumulates in xrn1D cells. Consistent with this notion, we found that the cytoplasmic exosome also contributes to HAC1 intron turnover ( Figure 3H ), but this mode of decay is unlikely to regulate the UPR as the growth of ski2D cells is unaffected by tunicamycin ( Figure 1B) .
KMD of 3 -exon
Trl1
HAC1 ligation
In trl1D (RtcB) cells, excised HAC1 intron accumulates as a circle, evinced by its altered mobility and resistance to Xrn1-mediated decay in vivo ( Figure 3F) , and its resistance to RNase R degradation in vitro ( Figure 3G) . Circularization of the HAC1 intron by RtcB in trl1D cells is facilitated by 5 0 -OH and 2 0 ,3 0 -cyclic PO 4 termini created by Ire1 cleavage and the absence of Trl1 end modification activities that could otherwise produce termini incompatible with RtcB ligation (5 0 -PO 4 or adenylylate; and 2 0 -PO 4 /3 0 -OH). It is noteworthy that circularized intron accumulates to high levels in the absence of tunicamycin ( Figure 3F and G), indicating that Ire1 catalyzes a low level of intron excision (and 3 0 -exon excision ( Figure 1C) ) from HAC1 u during normal growth, leading to the accumulation of stable, circularized introns in the presence of RtcB. (lanes 1-4) , whereas trl1D (RtcB), and trl1D xrn1D (RtcB) cells accumulate a slower-migrating species (~500 nt; lanes 5-8). (G) Cells expressing RtcB accumulate circular HAC1 intron. To test whether the slower-migrating band was circularized, total RNA was treated with RNase R and analyzed by northern blot. The slower-migrating species is largely protected from degradation, indicating it is a circle. Linear The HAC1 intron and 5 0 -UTR form an extensive base-pairing interaction that inhibits ribosome initiation (Chapman and Walter, 1997; Di Santo et al., 2016) . Thus, together these data evoke a model in which kinase-mediated decay of the excised HAC1 intron is required for HAC1 s translation, and a failure to degrade HAC1 intron-even when HAC1 s is produced-prevents HAC1 s translation and subsequent expression of stress-responsive genes. Despite their ability to make HAC1 s , xrn1D
and trl1D (RtcB) cells have growth defects on media containing tunicamycin ( Figure 3A ) and the relative severity of their defects parallels the accumulation of excised intron in these cells. Cells lacking Xrn1 have a modest growth defect and accumulate linear intron, which can be degraded by other exonucleases (Figure 3) . In contrast, trl1D (RtcB) cells have a severe growth defect and accumulate high levels of a stable, circularized intron that is immune to exonucleolytic decay ( Figure 3F and G) . We believe these findings resolve the mystery of the previously identified 'second function' of Trl1 required for UPR activation (Mori et al., 2010) , namely that-in addition to its ligase activity-Trl1 initiates kinase-mediated decay of the excised HAC1 intron, relieving its repressive effect on HAC1 s and activating translation.
Incompletely processed HAC1 s mRNA is endonucleolytically cleaved and degraded
In addition to the canonical 5 0 -exon product of 5 0 -splice site cleavage, a second product uniquely accumulates in tpt1D and tpt1D ski2D cells that is~50 nt shorter than full-length 5 0 -exon ( Figure 4A ). Expression of a catalytically inactive form of Tpt1 (Tpt1-R138A, (Sawaya et al., 2005) ) in tpt1D cells failed to rescue this defect ( Figure 4B) , affirming that the catalytic activity of Tpt1 is required to prevent accumulation of the shorter 5 0 -exon fragment. A corresponding elongated 3 0 -exon fragment accumulates in tpt1D, and more intensely in tpt1D xrn1D cells, indicating it is degraded by Xrn1 ( Figure 4C-E) . The elongated 3 0 -exon is specifically detected using a northern probe with a sequence complementary to the distal 3 0 -end of the 5 0 -exon ( Figure 4C,D) , indicating that a portion of the 5 0 -exon is responsible for the increased size of this decay intermediate. Moreover, a fragment of similar size hybridizes to a probe for the 3 0 -exon, suggesting that the sequence derived from 5 0 -exon is linked to the 3 0 -exon ( Figure 4E ); together these data indicate that HAC1 s is cleaved upstream of the 2 0 -phosphorylated ligation junction in tpt1D cells, and these products are degraded by both Xrn1 and the cytoplasmic exosome.
To determine whether HAC1 s sequence is sufficient for cleavage, we expressed plasmid-encoded HAC1 u and HAC1 s in hac1D cells to identify HAC1 splicing intermediates. We performed the analysis on trl1D cells, reasoning that if HAC1 s sequence were sufficient to cause cleavage, we would expect an accumulation of 3 0 -exon in cells unable to carry out ligation or degrade the products by kinasemediated decay. Tunicamycin treatment of trl1D hac1D cells expressing HAC1 u caused Ire1-mediated cleavage and accumulation of cleaved 3 0 -exon ( Figure 4F ). However, we found that full length HAC1 s was the only product produced in the trl1D hac1D cells in the presence and absence of tunicamycin ( Figure 4F ). Furthermore, expression of HAC1 s in a tpt1D background failed to produce additional fragments ( Figure 4G ), whereas expression of HAC1 u is sufficient in the tpt1D background to produce free HAC1 3 0 -exon, consistent with its secondary cleavage. Together, these results ( Figure 4F and G) indicate that the HAC1 s transcript is not sufficient to recapitulate the secondary cleavage, and that HAC1 u must be cleaved and ligated to produce the 2 0 -phosphorylated HAC1 s secondary cleavage substrate. To further characterize this secondary cleavage product, we determined the 5 0 end of the elongated 3 0 -exon. We analyzed the 5 0 -ends of cleaved 3 0 -exon by primer extension and found that cleaved 3 0 -exon was barely detectable in wild-type cells upon tunicamycin addition, whereas 3 0 -exon accumulated in trl1D cells due to a lack of kinase-mediated decay ( Figure 5A) . In tpt1D cells treated with tunicamycin, two products accumulated upon tunicamycin addition: a product consistent with canonical length 3 0 -exon and a small amount of elongated 3 0 -exon ( Figure 5A ). The elongated product accumulated in tpt1D xrn1D cells, again indicating it is degraded by Xrn1 ( Figure 5A ). To test this prediction (summarized in Figure 5B ), we measured the susceptibility of 3 0 -exon fragments to treatment in vitro with recombinant Xrn1 (rXrn1/TEX). As expected, fragments from xrn1D cells were degraded by rXrn1 ( Figure 5C ), establishing that they have 5 0 -PO 4 termini, whereas 3 0 -exon fragments from trl1D cells were resistant to rXrn1 degradation ( Figure 5C ), indicating that they have 5 0 -OH termini. The instructive findings came from examining 3 0 -exon accumulation in tpt1D cells. The 3 0 -exon fragment of canonical length that accumulates in tpt1D cells was resistant to rXrn1 treatment ( Figure 5C ), while the elongated fragment of 3 0 -exon is susceptible to rXrn1 treatment ( Figure 5C , lanes 15 and 16). These observations indicate that 3 0 product of secondary cleavage of HAC1 s is a substrate of Xrn1 in vivo and in vitro, raising the possibility that it may also be a substrate of kinasemediated decay, depending on the chemistry of the endoribonuclease that generates the secondary cleavage. We propose these products are created via two steps: (i) HAC1 s is cleaved~50 nt upstream of the 2 0 -phosphorylated ligation junction; (ii) Xrn1 partially degrades the intermediate fragment to the site of 2 0 -phosphorylation, which inhibits further degradation ( Figure 5D ). Under this model, the 3 0 -exon fragment that accumulates in tpt1D cells has both 5 0 -PO 4 and 2 0 -PO 4 moieties at its first position, which inhibits Xrn1-mediated decay in vivo and in vitro ( Figures 1C,  4D , 5A and C).
The accumulation of HAC1 decay intermediates in tpt1D cells over time further supports a model of HAC1 s cleavage by Ire1. In tpt1D cells, the accumulation of secondary cleavage product coincides with the increase in production of HAC1 s at 20 min ( Figure 6) . In tpt1D cells, cleaved HAC1 3 0 -exon is present at low levels at steady state and accumulates over the course of two hours upon tunicamycin treatment ( Figure 6A) . HAC1 s is also generated in tpt1D cells, but at significantly reduced levels compared to wild-type ( Figure 6A ). It is also notable that tpt1D xrn1D cells and tpt1D ski2D cells accumulate more spliced HAC1 s than tpt1D cells ( Figure 6E ), suggesting that some HAC1 s molecules or splicing intermediates in tpt1D cells are degraded, possibly because they contain 2 0 -PO 4 moieties. At all time points, tpt1D cells contain more free 3 0 -exon than HAC1 s , a ratio opposite to wild-type cells ( Figure 6A ), indicating that that 3 0 -exon cleaved from HAC1 u accumulates as a result of partial decay of 5 0 -and 2 0 -phosphorylated HAC1 s . The augmented accumulation of 3 0 -exon in tpt1D cells is also observed in the primer extension analysis ( Figure 5A ). The in vitro ability of Xrn1 to only partially degrade elongated HAC1 3 0 -exon from tpt1D xrn1D cells, and inability to degrade canonical 3 0 -exon from tpt1D cells, indicates that the accumulation of free HAC1 3 0 -exon is likely caused primarily by blocked 5 0 fi3 0 degradation.
Discussion
Many different regulatory events impinge on HAC1 mRNA to control its localization and processing. It has been assumed that cleavage of HAC1 u by Ire1 is the rate-limiting step for UPR activation.
Counter to this view, we found that decay of HAC1 splicing intermediates is required for both UPR activation and suppression. We found several examples wherein 'kinase-mediated decay' (KMD) degrades HAC1 splicing intermediates containing 5 0 -OH termini by sequential 5 0 -phosphorylation and 5 0 -phosphate-dependent 5 0 fi3 0 exonucleolytic degradation ( Figure 7) . We propose that after 3 0 -splice site cleavage by Ire1, the Trl1 5 0 -kinase domain associates with and phosphorylates the 5 0 -OH of the 3 0 -exon product (Figure 7) . Dissociation of the Trl1 kinase active site from the 5 0 -PO 4 product then enables a competition between reassociation of Trl1 (now A B C D Figure 5 . A 5 0 -and 2 0 -phosphorylated HAC1 decay intermediate inhibits Xrn1. (A) Primer extension analysis of HAC1 3 0 -exon cleavage products. Primer extension using a probe for 3 0 -exon was performed on total RNA from wild-type, tpt1D (10x tRNA), tpt1D xrn1D (10x tRNA), and trl1D (10x tRNA) cells treated with or without tunicamycin. A loading control for U6 snRNA is depicted in the bottom panel. The extension product of cleaved 3 0 -splice site is 174 nt, found in wild-type cells treated with tunicamycin (lane 2) and is present in untreated trl1D cells but increases upon tunicamycin treatment (lanes 7 and 8). An extension product from tpt1D cells accumulates upon tunicamycin treatment (lanes 3 and 4) and co-migrates with the product from wildtype (lane 2) and trl1D (lane 8) cells. In addition, a faint elongated product at~225 nt is present in tpt1D cells (lane 4). This elongated product accumulates to higher levels in tpt1D xrn1D cells treated with tunicamycin (lane 6). (B) Model of HAC1 3 0 -exon primer extension product lengths. A 5 0 -radiolabeled (yellow star) primer (HAC1 3 0 -exon probe, see Table 2 ) anneals to HAC1 3 0 -exon mRNA and primes cDNA synthesis by a reverse transcriptase. The reverse transcriptase stops synthesizing cDNA when it runs out of RNA template at the 5 0 -terminus of the 3 0 -exon. The model shows three situations as observed in (A): 1) canonical 3 0 -exon cleavage fragments (lower right), as observed in trl1D cells; 2) extended HAC1 3 0 -exon (above reaction arrow), as caused by secondary cleavage of HAC1 s , observed in tpt1D xrn1D (10x) cells; and 3) extended HAC1 3 0 -exon on which Xrn1 (cellular or in vitro) initiated decay, but failed to proceed past the 2 0 -P (beneath arrow). (C) Susceptibility of 3 0 -exon cleavage products to in vitro Xrn1 degradation. Total RNA from (A) was treated with recombinant Xrn1 (rXrn1) and analyzed by primer extension for the 3 0 -exon. The loading control performed on U6 snRNA is depicted in the bottom panel. The 3 0 -exon from trl1D cells accumulates upon tunicamycin treatment (compare lanes 1 and 2 to 3 and 4) but the 3 0 -exon is resistant to rXrn1 (lanes 3 and 4) because it lacks a 5 0 -phosphate due to lack of Trl1 5 0 -kinase activity in these cells. In contrast, the 3 0 -exon products from xrn1D cells, which have Trl1 5 0 -kinase and thus 5 0 -phosphates, are degraded by rXrn1 (lanes 6 and 8). The 3 0 -exon product in tpt1D cells is resistant to rXrn1 treatment (compare lanes 9 to 10, and 11 to 12), despite the fact these cells have both Trl1 and Xrn1. The its adenylyltransferase/ligase domain) to catalyze ligation-or Xrn1 to catalyze degradation. In some circumstances, this balance is tipped to favor ligation even in the absence of overt UPR stimulation: a lack of decay in xrn1D cells favors ligation, whereas the lack of 5 0 -kinase activity in trl1D (RtcB) cells renders Xrn1 decay irrelevant ( Figure 2E and F) . Xrn1 is abundant in budding yeast (Ghaemmaghami et al., 2003) , which may efficiently suppress the UPR under normal conditions by degrading spuriously cleaved HAC1 3 0 -exon intermediates. Regulation of the ligation step of HAC1 s splicing makes intuitive sense because it is the last opportunity to act during splicing; once ligated, HAC1 s is again protected by a 7-methylguanosine cap and a poly-(A) tail. Spurious HAC1 splicing was previously reported in trl1D cells expressing the tRNA ligase from Arabidopsis thaliana (Mori et al., 2010) . It is noteworthy that there are mechanistic differences between the tRNA ligases of A. thaliana and another yeast (K. lactis) (Remus and Shuman, 2014) , suggesting that these differences could impact the balance between kinase-mediated decay and ligation in budding yeast expressing plant RNA ligase. We also found that excised HAC1 intron is a substrate of kinase-mediated decay (Figure 3) . Indeed, we believe that phosphorylation of HAC1 intron by Trl1 to promote kinase-mediated decay is the previously proposed 'second role' of Trl1 ligase in activating HAC1 translation independent of ligation (Mori et al., 2010) . In this previous study, excised and circularized HAC1 intron was found to remain associated with HAC1 s , inhibiting translation. Kinase-mediated decay of excised intron therefore likely relieves the long-range base-pairing interaction that prevents HAC1 s translation (Chapman and Walter, 1997; Di Santo et al., 2016; Rüegsegger et al., 2001) , explaining how HAC1 s can accumulate without concomitant UPR activation. This second layer of control over HAC1 s translation by KMD adds another failsafe mechanism to prevent its translation and unintentional UPR activation. Previous examples of kinase-mediated decay of bacterial mRNAs (Durand et al., 2012) , eukaryal tRNA introns (Wu and Hopper, 2014) , ribosomal RNA processing intermediates (Gasse et al., 2015) , and no-go mRNA decay cleavage products (Navickas et al., 2018) suggest that this mode of decay may be widespread. Coupling of RNA 5 0 -kinase and 5 0 fi3 0 exonucleolytic decay activities in the context of kinase-mediated decay may regulate the UPR in other organisms. Splicing of Xbp-1 mRNA in metazoans (the functional homolog of HAC1) is catalyzed by Ire1-mediated removal of an intron and ligation by RtcB RNA ligase (Kosmaczewski et al., 2014; Lu et al., 2014) . Fundamental differences in the chemistry of RNA ligation between fungal and metazoan ligases suggest that Xbp-1 may be subject to a biochemically distinct mode of regulation. Because RtcB depends on 5 0 -OH and 3 0 -PO 4 termini for catalysis (Chakravarty et al., 2012) , activities that remodel 5 0 -OH RNA termini could divert Ire1-generated 5 0 -OH splicing intermediates from productive ligation. To that point, cyclic nucleotide phosphodiesterase (CNP) and RtcA (a 2 0 ,3 0 -RNA cyclase) were shown to 'tune' the UPR in metazoans by competing with RtcB/HSCP117 for ligation substrates (Unlu et al., 2018) . Specifically, CNP hydrolyzes the 2 0 ,3 0 -cyclic phosphate compatible RtcB to a 2 0 -PO 4 incompatible with RtcB, decreasing ligation of Xbp1. Conversely, RtcA, which converts 2 0 -PO 4 RNA to 2 0 ,3 0 -cyclic phosphate, makes the terminus compatible with RtcB, thus enhancing Xbp1 splicing.
Additionally, an RNA 5 0 -kinase (e.g., Clp1) may phosphorylate the 3 0 -exon product of Xbp-1 cleavage, simultaneously inhibiting ligation by RtcB and promoting its degradation by a 5 0 -phosphatedependent exoribonuclease to limit UPR activation. In this vein, it is noteworthy that kinase-inactivating mutations in Clp1 cause neurodevelopmental defects and neuronal dysfunction in humans, mice, and zebrafish (Hanada et al., 2013; Karaca et al., 2014; Schaffer et al., 2014) , possibly due to chronic UPR activation in neural tissues (Clayton and Popko, 2016) . Xrn1 degrades mRNA fragments generated during metazoan Regulated Ire1-dependent Degradation (RIDD) (Hollien and Weissman, 2006) ; however, it is not known how these 5 0 -OH cleavage products of Ire1 are phosphorylated for Xrn1-mediated decay. The RNA 5 0 -kinase Clp1 (Weitzer and Martinez, 2007) and polynucleotide kinase Nol9 (Heindl and Martinez, 2010) are candidates for this activity, though neither are known to phosphorylate mRNA decay intermediates.
While 5 0 fi3 0 decay plays a major role in UPR regulation, we found little evidence for UPR regulation by 3 0 fi5 0 decay activity. As shown previously (Schwer et al., 2004) , the exposed 3 0 -end of cleaved HAC1 5 0 -exon is a substrate for 3 0 decay of the excised intron does not contribute substantially to intron-mediated HAC1 s repression.
We also found evidence that incompletely processed HAC1 s mRNA is cleaved, which is ligated but contains an internal 2 0 -PO 4 moiety. Cleavage of HAC1 s leads to 5 0 and 3 0 fragments that are degraded; however, the 3 0 -fragment is only partially degraded by kinase-mediated decay, producing a 5 0 -and 2 0 -phosphorylated molecule that cannot be degraded by Xrn1. Consistent with these findings, a recent study also showed that an RNA with an internal 2 0 -phosphate group is protected from 3 0 fi5 0 decay by E. coli PNPase in vitro (Munir et al., 2018) ; those and our results together indicate that site-specific installation of a 2 0 -PO 4 is an effective strategy to protect an RNA from complete exonucleolytic degradation in vivo or in vitro.
Decay intermediates produced from incompletely processed, 2 0 -phosphorylated HAC1 s have not been previously observed and suggest a plausible regulatory role for Tpt1 in regulating HAC1 s fate.
We have yet to determine the impact of 2 0 -phosphorylation on HAC1 s translation, but given that (Sidrauski and Walter, 1997) , precluding direct analysis of HAC1 s cleavage in ire1D mutants.
We showed that the 2 0 -PO 4 is required for cleavage, as expression of 'pre-spliced' HAC1 s does not lead to cleavage ( Figure 4F and G). It is possible that the presence of a 2 0 -PO 4 in the context of a composite Ire1 splice site (i.e., formed from two halves of the original 5 0 -and 3 0 -splice sites (Hooks and Griffiths-Jones, 2011; Sidrauski and Walter, 1997 )) on HAC1 s is recognized by Ire1, but because a 2 0 -OH is the nucleophile for transesterification by metal-independent Ire1 (Gonzalez et al., 1999) , the 2 0 -PO 4 inhibits the chemical step of incision. This model also provides a plausible mechanism to explain how Ire1 incises a neighboring, non-canonical site. We propose that a failure of Ire1 to release 2 0 -phosphorylated HAC1 s would enable the active site of a nearby Ire1 molecule-in the context of its activated, oligomeric form )-to catalyze site-specific incision at the second, upstream site. Our results also raise the question of why Ire1 would cut incompletely processed HAC1 s . Here, cleavage of incompletely processed (ligated, but 2 0 -phosphorylated) HAC1 s could be a means to inactivate HAC1 s after prolonged stimulation to attenuate the UPR (Chawla et al., 2011; Rubio et al., 2011) .
Materials and methods
Yeast strains and plasmids
Yeast strains and sources used in this study are listed in Table 3 . Plasmids were created as indicated in Table 3 .
Cell culture and RNA preparation
Single colonies were inoculated in drop-out media supplemented with relevant amino acids and incubated at 30˚C overnight with rotation. Cultures were diluted to an OD 600 of 0.2 in yeast-extract, peptone, dextrose (YPD) media, and UPR induction was carried out when yeast were growing at mid-log phase with a 2 hr treatment (unless otherwise indicated) with tunicamycin (final concentration of 2.5 mg/mL, Sigma-Aldrich) or DMSO mock treatment. Cells were harvested by centrifugation, and total RNA was isolated by hot acid phenol extraction. For RT-PCR and RT-qPCR experiments, total RNA was treated with TURBO DNase (2 U, Ambion) to degrade contaminating genomic DNA.
RT-PCR/qPCR
DNase-treated RNA was reverse transcribed with 200 U of SuperScript III reverse transcriptase (Invitrogen) using a gene-specific reverse primer ( Table 2) . Products analyzed on a 1.5% agarose TBE gel, stained with 1x GelRed (Sigma) and imaged with a Bio Rad GelDoc. Densitometry was performed with Bio-Rad Image Analysis software and splicing quantifications were computed and visualized in R using ggplot2 and cowplot R Packages. Quantitative PCR (qPCR) for KAR2 was also performed on cDNA as generated above, and assayed for KAR2 and PGK1 using Sso Advanced Universal SYBR Green Supermix (Bio Rad) and cycled on a Bio Rad C1000 384-well thermal cycler and plate reader. Output C t values were analyzed in Microsoft Excel and plotted in R using ggplot2 and cowplot R Packages. 
Primer extension
Primers specific for HAC1 mRNA and U6 snRNA were PAGE-purified and ethanol precipitated. Oligonucleotide primers were 5 0 -end-labeled with PNK (Enzymatics) and g-32 P-ATP (Perkin Elmer) and purified with Sephadex G-25 spin columns (GE Healthcare resin, Thermo empty columns). Radiolabeled primers and total RNA (15 mg) were heated to 65˚C for 5 min and cooled to 42˚C. SuperScript III reverse transcriptase (200 U, Invitrogen) was added and reverse transcription reactions were run with a final concentration of 500 mM dNTPs. Primers were extended for 30 min at 42˚C, 15 min at 45˚C, and 15 min at 50˚C. SuperScript III RT was inactivated by heating for 20 min at 75˚C. RNA was destroyed with in 10 mM NaOH at 90˚C for 3 min and neutralized with HCl. Formamide loading dye was added and products were run on a 8% acrylamide TBE 7M Urea gel. Gels were dried (Bio Rad) and exposed on a phosphor-imager screen and imaged on a Typhoon 9400 (GE Healthcare). (MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15} ). 
Northern blotting
Total RNA (3 mg) was electrophoresed on 6% acrylamide TBE 7M urea gels and transferred to nylon membrane (Hybond N+, GE) by electroblotting. Membranes were UV-crosslinked (254 nm, 120 mJ dose), blocked in ULTRAhyb-Oligo Buffer (Ambion), and incubated with 5 0 -32 P-labeled oligonucleotide probes (Table 2) in ULTRAhyb-Oligo at 42˚C for 18 hr. Membranes were washed with 2X SSC/ 0.5% SDS washing buffer two time for 30 min each, exposed on a phosphor-imager storage screen, and imaged on a Typhoon 9400 (GE Healthcare). Membranes were stripped of original probe with three washes in stripping buffer (2% SDS) at 80˚C for 30 min per wash. Membranes were re-blocked and probed a second time for the loading control, SCR1 ( Table 2 ).
